Evaluation of a New Cardiac Biomarker Assay

Completed · Phase 3

Conditions studied: Acute Coronary Syndrome, Acute Myocardial Infarction

In brief

The objective of the study is to evaluate the performance and intended use of a new cardiac biomarker test, Troponin I, in an intended use population. Blood specimens will be tested using the new investigational test that detects the level of Troponin I. Results will be compared to the diagnosis of whether or not an acute myocardial infarction (MI) occurred.

Key facts

Study ID
NCT01608100
Run by
Abbott Diagnostics Division
People needed
1101
Starts
2012-06-01
Expected to finish
2014-09-01
Last updated by the study team
2015-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.